A detailed history of Hi Line Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hi Line Capital Management, LLC holds 35,982 shares of ABBV stock, worth $6.05 Million. This represents 2.87% of its overall portfolio holdings.

Number of Shares
35,982
Previous 35,477 1.42%
Holding current value
$6.05 Million
Previous $5.5 Million 19.19%
% of portfolio
2.87%
Previous 2.64%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $80,709 - $91,960
505 Added 1.42%
35,982 $6.55 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $470,454 - $529,842
-3,419 Reduced 8.79%
35,477 $5.5 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $14,427 - $16,702
-108 Reduced 0.28%
38,896 $5.8 Million
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $620,809 - $772,556
-4,685 Reduced 10.72%
39,004 $5.26 Million
Q1 2023

Apr 21, 2023

SELL
$144.61 - $166.54 $4.11 Million - $4.74 Million
-28,441 Reduced 39.43%
43,689 $6.96 Million
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $29,874 - $35,827
216 Added 0.3%
72,130 $11.7 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $221,983 - $254,600
1,654 Added 2.35%
71,914 $9.66 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $242,211 - $307,929
1,760 Added 2.57%
70,260 $10.8 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $86,314 - $107,092
654 Added 0.96%
68,500 $11.1 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $8,594 - $10,874
80 Added 0.12%
67,846 $9.19 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $225,568 - $256,053
2,120 Added 3.23%
67,766 $7.31 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $27,249 - $30,357
259 Added 0.4%
65,646 $7.39 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $6.69 Million - $7.36 Million
65,387 New
65,387 $7.08 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hi Line Capital Management, LLC Portfolio

Follow Hi Line Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hi Line Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hi Line Capital Management, LLC with notifications on news.